Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: VOLGA Trial - ctDNA Clearance in Cisplatin-Ineligible MIBC With Durvalumab + Tremelimumab + Enfortumab Vedotin
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Alexandra Drakaki
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Alexandra Drakaki
51 views
September 23, 2024
Comments 0
Login to view comments.
Click here to Login